Cristian George Tieranu
Overview
Explore the profile of Cristian George Tieranu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
90
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Olteanu A, Ionescu E, Tieranu C, Popa L, Andrei S, Preda C, et al.
Diagnostics (Basel)
. 2025 Mar;
15(5).
PMID: 40042385
The authors wish to correct the authorship of the original publication [...].
2.
Olteanu A, Klimko A, Tieranu I, Orzan O, Toma C, Ionescu E, et al.
Medicina (Kaunas)
. 2025 Feb;
61(2).
PMID: 40005480
In the original publication [...].
3.
Tieranu C, Balaban D, Tabacelia D, Klimko A, Gheorghe C, Pereira S, et al.
Diagnostics (Basel)
. 2025 Feb;
15(4).
PMID: 40002589
Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) has recently been proposed as an alternative treatment option for patients with unresectable pancreatic adenocarcinoma (uPDAC) or metastatic pancreatic adenocarcinoma (mPDAC). This review aims to...
4.
Podina N, Gheorghe E, Constantin A, Cazacu I, Croitoru V, Gheorghe C, et al.
United European Gastroenterol J
. 2025 Jan;
13(1):55-77.
PMID: 39865461
The rising incidence of pancreatic diseases, including acute and chronic pancreatitis and various pancreatic neoplasms, poses a significant global health challenge. Pancreatic ductal adenocarcinoma (PDAC) for example, has a high...
5.
Olteanu A, Klimko A, tieranu E, Bota A, Preda C, Tieranu I, et al.
Biomedicines
. 2024 Nov;
12(11).
PMID: 39595001
Background And Aims: Postoperative recurrence in Crohn's disease remains a significant clinical challenge, with high recurrence rates despite advancements in medical therapy. This study aims to evaluate the efficacy of...
6.
Edu A, Pahomeanu M, Ghita A, Constantinescu D, Grigore D, Bota A, et al.
Diagnostics (Basel)
. 2024 Jun;
14(11).
PMID: 38893632
(1) Background: Hypertriglyceridemia (HTG) is a well-known metabolic condition associated with an increased risk of acute pancreatitis. In this study, we tried to establish whether there are any significant disparities...
7.
Klimko A, Olteanu A, Tieranu I, Orzan O, Toma C, Ionescu E, et al.
Medicina (Kaunas)
. 2024 Jan;
60(1).
PMID: 38256367
Ustekinumab (UST), a biologic agent targeting interleukin-12 and interleukin-23, is widely used in the management of psoriasis and Crohn's disease. Despite its efficacy, there have been instances of paradoxical psoriasis...
8.
Pavel C, Diculescu M, Stepan A, Constantinescu G, Sandru V, Tieranu C, et al.
J Clin Med
. 2024 Jan;
13(1).
PMID: 38202296
Monitoring disease activity in inflammatory bowel disease (IBD) is challenging since clinical manifestations do not represent reliable surrogates for an accurate reflection of the inflammatory burden. Endoscopic remission had been...
9.
Orzan O, Tieranu C, Olteanu A, Dorobantu A, Cojocaru A, Mihai M, et al.
Pharmaceutics
. 2023 Aug;
15(8).
PMID: 37631384
Psoriasis is a chronic, inflammatory, multisystemic disease which affects approximately 2-3% of the population globally, whose onset is triggered by genetic and environmental factors which activate both dendritic cells and...
10.
Olteanu A, Ionescu E, Tieranu C, Popa L, Andrei S, Preda C, et al.
Diagnostics (Basel)
. 2023 May;
13(8).
PMID: 37189566
Introduction: Multiple cytokines have been studied for their role in the propagation of the inflammatory process related to inflammatory bowel diseases (IBD), but the role of interleukin-4 remains controversial. The...